Application note: Cell-Based Therapies – Be on the Safe Side
Posted: 8 August 2019 | Sartorius | No comments yet
This Application note discusses how you can obtain on-time QC results within three hours to ensure your patient’s safety. It details the Microsart® ATMP Mycoplasma (a rapid real-time PCR mycoplasma detection kit for testing ATMPs) and the Microsart® ATMP Bacteria (for the sterility testing of cell culture samples including ATMPs).
Related content from this organisation
- Quality from the start: designing a scalable AAV production platform
- European Pharmaceutical Review Issue 4 2024
- Application note: Equivalency of PCR-based rapid sterility testing and the compendial culture method
- Product hub: Choosing the right tool for method screening and process optimisation
- Microbial fermentation tech market to exceed $56.9b by 2033